Corporate Governance5 Nov 2026, 08:02 pm
Dr. Agarwal's Health Care Ltd: IPO Proceeds Utilization Report Submitted
AI Summary
Dr. Agarwal's Health Care Limited has submitted its Monitoring Agency Report for the quarter ended September 30, 2026, prepared by ICRA Limited. The report confirms that the utilization of Initial Public Offer (IPO) proceeds is in line with the objects of the issue, with no material deviation observed. The offer-related expenses decreased, leading to a revision in the General Corporate Purpose amount to ₹92.350 crore from ₹77.466 crore, which is within the permissible limit of 35% of gross proceeds. The company's IPO was opened on January 29, 2025, and closed on January 31, 2025, with an issue size of ₹3,027.260 Crore.
Key Highlights
- IPO proceeds utilization is in line with stated objectives.
- No material deviation in fund utilization reported.
- General Corporate Purpose allocation revised to ₹92.350 crore.
- Offer-related expenses were lower than estimated.
- Report submitted as per SEBI regulations.
Price Impact
More from AGARWALEYE